484 On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon α-2a (40 kDa) (PEGASYS®)
- 30 April 2005
- journal article
- abstracts
- Published by Elsevier BV in Journal of Hepatology
- Vol. 42, 175
- https://doi.org/10.1016/s0168-8278(05)81896-3